Cancer
Advancing Cancer Immunotherapy Using Lipid Nanoparticle-Based Approaches
Research from the Department of Pathology and the Federal University of Minas Gerais has shed new light on the potential of lipid nanoparticle-based approaches in advancing cancer immunotherapy. According to the study, lipid nanoparticles offer promising solutions to overcome challenges in cancer treatment, including production, systemic toxicity, and inefficient delivery.